![Nico Mertens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Nico Mertens worked as the Director of Antibody Engineering Programmes at Biotecnol-Serviços e Desenvolvimento SA. He graduated from Ghent University with an undergraduate degree and also earned an MBA from Hogeschool-Universiteit Brussel in 2002.
Additionally, he obtained another undergraduate degree from the University of Antwerp.
Antiguos cargos conocidos de Nico Mertens.
Empresas | Cargo | Fin |
---|---|---|
Biotecnol-Serviços e Desenvolvimento SA
![]() Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Corporate Officer/Principal | - |
Formación de Nico Mertens.
Ghent University | Graduate Degree |
University of Antwerp | Undergraduate Degree |
Hogeschool-Universiteit Brussel | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Biotecnol-Serviços e Desenvolvimento SA
![]() Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Commercial Services |
- Bolsa de valores
- Insiders
- Nico Mertens